The Effect of Multiple Doses of Itraconazole on the Single-dose Pharmacokinetics of BI 3031185 Following Oral Administration in Healthy Trial Participants (an Open-label, Two-period, Fixed- Sequence Design Study)
Latest Information Update: 31 Oct 2025
At a glance
- Drugs BI 3031185 (Primary)
- Indications Attention-deficit hyperactivity disorder; Borderline personality disorders
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim; Boehringer Ingelheim GmbH International
Most Recent Events
- 24 Oct 2025 Status changed from not yet recruiting to recruiting.
- 26 Sep 2025 New trial record